Compare Nuwellis Inc (NUWE) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs PayPal Holdings, Inc. — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while PayPal Holdings, Inc. trades at $55.53 (market cap $47.07B). The key difference: PayPal Holdings, Inc. is far larger — about 21395.5× Nuwellis Inc's market cap, and PayPal Holdings, Inc. pays a 1.02% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and PayPal Holdings, Inc. for 106 Days on average.
| NUWE | PYPL | |
|---|---|---|
Market Cap | $2.20M | $47.07B |
Volume | 121,544 | 13,860,099 |
Sector | Health | Financials |
52-Week High | $146.65 | $75.75 |
52-Week Low | $0.68 | $39.08 |
Typical Hold Time | 26 Days | 106 Days |
Enterprise Value | -$1.52M | $49.21B |
Dividend Yield | — | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
PayPal trades at $55.53, up 1.06% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a P/E of 10.4, net income margin of 14.36%, and consistent revenue growth from $33.17B in 2025 to projected $34.1B in 2026. Recent partnerships with Meta and positive earnings beats in Q1 and Q2 2026 highlight operational momentum, though Q4 2025 missed expectations.
Outlook: Attractive valuation and strategic initiatives under new CEO Enrique Lores support upside potential. Risks include competitive pressures in digital payments and execution challenges in turnaround efforts. Analyst consensus price target of $56.41 suggests modest near-term appreciation from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
